205 related articles for article (PubMed ID: 35665561)
1. EWSR1::YY1 fusion positive peritoneal epithelioid mesothelioma harbors mesothelioma epigenetic signature: Report of 3 cases in support of an emerging entity.
Dermawan JK; Torrence D; Lee CH; Villafania L; Mullaney KA; DiNapoli S; Sukhadia P; Benayed R; Borsu L; Agaram NP; Nash GM; Dickson BC; Benhamida J; Antonescu CR
Genes Chromosomes Cancer; 2022 Oct; 61(10):592-602. PubMed ID: 35665561
[TBL] [Abstract][Full Text] [Related]
2. A Subset of Malignant Mesotheliomas in Young Adults Are Associated With Recurrent EWSR1/FUS-ATF1 Fusions.
Desmeules P; Joubert P; Zhang L; Al-Ahmadie HA; Fletcher CD; Vakiani E; Delair DF; Rekhtman N; Ladanyi M; Travis WD; Antonescu CR
Am J Surg Pathol; 2017 Jul; 41(7):980-988. PubMed ID: 28505004
[TBL] [Abstract][Full Text] [Related]
3. NR4A3 fusions characterize a distinctive peritoneal mesothelial neoplasm of uncertain biological potential with pure adenomatoid/microcystic morphology.
Agaimy A; Brcic L; Briski LM; Hung YP; Michal M; Michal M; Nielsen GP; Stoehr R; Rosenberg AE
Genes Chromosomes Cancer; 2023 May; 62(5):256-266. PubMed ID: 36524687
[TBL] [Abstract][Full Text] [Related]
4. Intra-Abdominal Epithelioid Neoplasm With EWSR1::CREB Fusions Involving the Kidney: A Clinicopathologic and Molecular Characterization With an Emphasis on Differential Diagnosis.
Zhao M; Gan H; Zhong S; Xia Q; Bai Y; Xu J; Teng X; Wang J
Mod Pathol; 2024 May; 37(5):100468. PubMed ID: 38460673
[TBL] [Abstract][Full Text] [Related]
5. EWSR1/FUS-CREB fusions define a distinctive malignant epithelioid neoplasm with predilection for mesothelial-lined cavities.
Argani P; Harvey I; Nielsen GP; Takano A; Suurmeijer AJH; Voltaggio L; Zhang L; Sung YS; Stenzinger A; Mechtersheimer G; Dickson BC; Antonescu CR
Mod Pathol; 2020 Nov; 33(11):2233-2243. PubMed ID: 32770123
[TBL] [Abstract][Full Text] [Related]
6. RNA sequencing identifies fusion of the EWSR1 and YY1 genes in mesothelioma with t(14;22)(q32;q12).
Panagopoulos I; Thorsen J; Gorunova L; Micci F; Haugom L; Davidson B; Heim S
Genes Chromosomes Cancer; 2013 Aug; 52(8):733-40. PubMed ID: 23630070
[TBL] [Abstract][Full Text] [Related]
7. Cytokeratin-positive Malignant Tumor in the Abdomen With EWSR1/FUS-CREB Fusion: A Clinicopathologic Study of 8 Cases.
Shibayama T; Shimoi T; Mori T; Noguchi E; Honma Y; Hijioka S; Yoshida M; Ogawa C; Yonemori K; Yatabe Y; Yoshida A
Am J Surg Pathol; 2022 Jan; 46(1):134-146. PubMed ID: 34049318
[TBL] [Abstract][Full Text] [Related]
8. Malignant Mesothelioma With
Ren H; Rassekh SR; Lacson A; Lee CH; Dickson BC; Chung CT; Lee AF
Pediatr Dev Pathol; 2021; 24(6):570-574. PubMed ID: 34121509
[TBL] [Abstract][Full Text] [Related]
9. Genomic profiling of malignant peritoneal mesothelioma reveals recurrent alterations in epigenetic regulatory genes BAP1, SETD2, and DDX3X.
Joseph NM; Chen YY; Nasr A; Yeh I; Talevich E; Onodera C; Bastian BC; Rabban JT; Garg K; Zaloudek C; Solomon DA
Mod Pathol; 2017 Feb; 30(2):246-254. PubMed ID: 27813512
[TBL] [Abstract][Full Text] [Related]
10. Pediatric Mesothelioma With ALK Fusions: A Molecular and Pathologic Study of 5 Cases.
Argani P; Lian DWQ; Agaimy A; Metzler M; Wobker SE; Matoso A; Epstein JI; Sung YS; Zhang L; Antonescu CR
Am J Surg Pathol; 2021 May; 45(5):653-661. PubMed ID: 33399341
[TBL] [Abstract][Full Text] [Related]
11. CREB fusion-associated epithelioid mesenchymal neoplasms of the female adnexa: three cases documenting a novel location of an emerging entity and further highlighting an ambiguous misleading immunophenotype.
Trecourt A; Macagno N; Ngo C; Philip CA; Lopez J; Ferreira J; Alves-Vale C; Ray-Coquard I; Genestie C; Agaimy A; Devouassoux-Shisheboran M
Virchows Arch; 2023 Jun; 482(6):967-974. PubMed ID: 37097347
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of diffuse malignant peritoneal mesothelioma.
Hung YP; Dong F; Torre M; Crum CP; Bueno R; Chirieac LR
Mod Pathol; 2020 Nov; 33(11):2269-2279. PubMed ID: 32504035
[TBL] [Abstract][Full Text] [Related]
13. [Clinicopathological study of epithelioid and spindle cell rhabdomysarcoma with EWSR1/FUS-TFCP2 fusion].
Li HL; Mo CH; Xie L; Wu YX; Zeng M; Mao RJ
Zhonghua Bing Li Xue Za Zhi; 2024 Jan; 53(1):58-63. PubMed ID: 38178748
[No Abstract] [Full Text] [Related]
14. Diffuse mesothelioma of the peritoneum: a pathological study of 64 tumours treated with cytoreductive therapy.
Lee M; Alexander HR; Burke A
Pathology; 2013 Aug; 45(5):464-73. PubMed ID: 23846294
[TBL] [Abstract][Full Text] [Related]
15. Ewing sarcoma with FEV gene rearrangements is a rare subset with predilection for extraskeletal locations and aggressive behavior.
Tsuda Y; Dickson BC; Swanson D; Sung YS; Zhang L; Meyers P; Healey JH; Antonescu CR
Genes Chromosomes Cancer; 2020 May; 59(5):286-294. PubMed ID: 31756779
[TBL] [Abstract][Full Text] [Related]
16. Identification of ALK Rearrangements in Malignant Peritoneal Mesothelioma.
Hung YP; Dong F; Watkins JC; Nardi V; Bueno R; Dal Cin P; Godleski JJ; Crum CP; Chirieac LR
JAMA Oncol; 2018 Feb; 4(2):235-238. PubMed ID: 28910456
[TBL] [Abstract][Full Text] [Related]
17. EWSR1::WT1 Fusions in Neoplasms Other Than Conventional Desmoplastic Small Round Cell Tumor: Three Tumors Occurring Outside the Female Genital Tract.
Warmke LM; Perret R; Ledoux P; Michot A; Italiano A; Zou YS; Matoso A; Argani P; Ulbright TM; Baumhoer D; Ameline B; Gross JM
Mod Pathol; 2024 Mar; 37(3):100418. PubMed ID: 38158126
[TBL] [Abstract][Full Text] [Related]
18. Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum.
Attanoos RL; Webb R; Dojcinov SD; Gibbs AR
Histopathology; 2002 Mar; 40(3):237-44. PubMed ID: 11895489
[TBL] [Abstract][Full Text] [Related]
19. Intra-abdominal EWSR1/FUS-CREM-rearranged malignant epithelioid neoplasms: two cases of an emerging aggressive entity with emphasis on misleading immunophenotype.
Agaimy A; Stoehr R; Otto M; Bräsen JH; Pfarr N; Konukiewitz B; Kasajima A; Hartmann A; Klöppel G
Virchows Arch; 2022 Feb; 480(2):481-486. PubMed ID: 34228212
[TBL] [Abstract][Full Text] [Related]
20. Molecular and Immunohistochemical Testing in Mesothelioma and Other Mesothelial Lesions.
Hung YP; Chirieac LR
Arch Pathol Lab Med; 2024 May; 148(5):e77-e89. PubMed ID: 38190277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
